Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Quote | Quest Diagnostics Incorporated (NYSE:DGX)
Last: | $145.59 |
---|---|
Change Percent: | -0.46% |
Open: | $144.92 |
Close: | $145.59 |
High: | $146.73 |
Low: | $144.57 |
Volume: | 1,074,540 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Quest Diagnostics Incorporated (NYSE:DGX)
2024-07-28 05:40:15 ET Summary Quest Diagnostics reported Q2 earnings beat on EPS and revenue, with 9.5% year-over-year revenue growth. Company's acquisitions and focus on expanding clinical services are key growth drivers. Despite strong earnings, risks include economic downt...
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
Message Board Posts | Quest Diagnostics Incorporated (NYSE:DGX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $DGX News Article - When Quest Diagnostics ($DGX) Moves Investors should Listen | whytestocks | investorshangout | 04/05/2023 4:40:46 PM |
whytestocks: $DGX News Article - ConferMED, through Grant from the Quest Diagnostics Foundation, now | whytestocks | investorshangout | 11/16/2022 7:10:51 PM |
whytestocks: $DGX News Article - Quest Diagnostics Reports First Quarter 2022 Financial Results; Rai | whytestocks | investorshangout | 04/21/2022 6:05:50 PM |
whytestocks: $DGX News Article - Quest Diagnostics Announces Leadership Succession Plan | whytestocks | investorshangout | 02/03/2022 6:06:10 PM |
whytestocks: $DGX News Article - QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCI | whytestocks | investorshangout | 02/03/2022 6:00:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-24 07:00:10 ET Eric Coldwell from Robert W. Baird issued a price target of $154.00 for DGX on 2024-07-24 06:36:00. The adjusted price target was set to $154.00. At the time of the announcement, DGX was trading at $140.96. The overall price target consensus is at ...
Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 PR Newswire Second quarter revenues of $2.40 billion , up 2.5% from 2023 Second quarter reported diluted earnings per share ("EPS") of $2.03 , down 1.0% from 2023; a...